Grace Therapeutics, Inc. · NASDAQ:GRCE

Opaleye Management Inc. bought 15,229 Grace Therapeutics, Inc. shares (Form 4)

Traded Sep 8 to Sep 9, 2026 · Filed Sep 10, 2026

From Sep 8 to Sep 9, 2026, Opaleye Management Inc. (10% owner) bought 15,229 Grace Therapeutics, Inc. shares at an average US$2.10 for US$31,923, leaving 2,775,229 shares. Filed Sep 10, 2026 (Form 4).

Bought
15,229 shares
Price
US$2.10 average (US$2.09 to US$2.10)
Value
US$31,923
Holding after
2,775,229 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 8, 2026Common Stock, par value $0.0001 per shareBuy9,393US$2.102,769,393Indirect
Sep 9, 2026Common Stock, par value $0.0001 per shareBuy5,836US$2.092,775,229Indirect

Source

View original at SEC

Related